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152Objective: Junctional ectopic tachycardia is common after pediatric heart surgery. After tetralogy of Fallot repair,
the incidence of junctional ectopic tachycardiamay be as high as 15% to 20%.We introduced prophylactic amio-
darone for tetralogy repair. This studywas conducted to evaluate the effectiveness of the prophylactic amiodarone.
Methods: A continuous infusion of amiodarone was started in the operating room at the time of rewarming dur-
ing cardiopulmonary bypass at a rate of 2 mg/kg/d and continued for 48 hours. Between November 2005 and
November 2009, 63 consecutive patients underwent primary repair of tetralogy, of whom 20 had prophylactic
amiodarone (amiodarone group) and 43 did not (control group). Variables studied included demographic and
bypass data, surgical procedure details (transannular or nontransannular patch), preoperative and postoperative
echocardiography findings, and postoperative inotropic support. Univariate and stepwise multivariate analyses
were conducted to determine factors associated with the occurrence of junctional ectopic tachycardia.
Results: The incidence of junctional ectopic tachycardia was 37% in the control group and 10% in the amio-
darone group. The groups were similar in age, weight, bypass time, rate of transannular patch usage, and pre-
operative and postoperative gradient through the right ventricular outflow tract. Prophylactic amiodarone was
significantly negatively associated with junctional ectopic tachycardia by both univariate (P ¼ .039) and mul-
tivariate (P ¼ .027) analyses. There were no adverse events attributable to prophylactic amiodarone use.
Conclusions: Prophylactic amiodarone is well tolerated and significantly associated with a decreased incidence
of junctional ectopic tachycardia after tetralogy repair. (J Thorac Cardiovasc Surg 2012;143:152-6)Junctional ectopic tachycardia (JET) is common after pedi-
atric heart surgery with an incidence reported between 2%
and 22%.1-3 JET has been reported after virtually every
type of congenital heart surgery, but seems particularly
common after ventricular septal defect repair, surgery for
single ventricle, arterial switch operation, total anomalous
pulmonary venous return repair, complete atrioventricular
canal repair, and tetralogy of Fallot (TOF) repair.4,5 The
incidence of JET after TOF repair has been reported to be
between 14% and 22%.1,5-7
This arrhythmia is usually transient, but because it may
cause significant morbidity and mortality by causing low
cardiac output syndrome, control of JET after pediatric
heart surgery is essential. However, the mechanism of this
arrhythmia after surgery is not well defined.6,7 Empiric
treatment of postoperative JET has included adequate
sedation, electrolyte control, hypothermia, and minimale University of Arkansas for Medical Sciences, Arkansas Children’s Hospital,
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The Journal of Thoracic and Cardiovascular Surginotropic support.8 In recent years, amiodarone has become
the treatment of choice.9-11
Amiodarone has been used as prophylaxis against atrial
fibrillation after adult cardiac surgery, but this approach
has not been tried in children undergoing cardiac surgery.
Because of a relatively high incidence of troublesome
JET after TOF repair at Arkansas Children’s Hospital, we
introduced prophylactic amiodarone in children undergoing
primary TOF repair. The purpose of this study is to review
the effectiveness of this prophylaxis and to identify any ad-
verse events associated with this novel strategy.MATERIALS AND METHODS
Via retrospective chart review, approved by the institutional review
board of the University of Arkansas for Medical Sciences, 63 consecutive
patients undergoing primary TOF repair between November 2005 and No-
vember 2009 at Arkansas Children’s Hospital were identified, and relevant
data were abstracted from hospital records. Patients who had undergone
prior palliation (n ¼ 17, most with pulmonary atresia) were excluded, as
were patients requiring right ventricle to pulmonary artery conduits, TOF
with major aortopulmonary collaterals, TOF absent pulmonary valve syn-
drome, and TOF atrioventricular canal defect. In mid-2007, we initiated
a strategy of prophylactic amiodarone continuous infusion in this patient
population. The drug was started in the operating room at the time of re-
warming during cardiopulmonary bypass at a rate of 2 mg/mg/d and con-
tinued for 48 hours. Among the 63 patients undergoing primary TOF repair,
20 received prophylactic amiodarone (amiodarone group) and 43 did not
(control group). In 2005 and 2006, all patients were in the control group.
In 2007, 18% of patients received prophylactic amiodarone; in 2008,
27% received prophylactic amiodarone; and in 2009, all patients were inery c January 2012
TABLE 1. Preoperative and operative patient data
Variables
Control
group (n ¼ 43)
Amiodarone
group (n ¼ 20)
P
value
Age (mo) 5.1  7.0 2.7  1.8 .12
Weight (kg) 5.9  2.3 5.3  1.5 .42
PG through RVOT
(mm Hg)
84  22 84  25 .87
Transannular patch 35 (81%) 18 (90%) .38
Cardiopulmonary
bypass time (min)
120  28 133  44 .33
Aortic crossclamp
time (min)
76  18 92  28 .029
PG, Pressure gradient; RVOT, right ventricular outflow tract.
TABLE 2. Postoperative profiles
Variables
Control
group (n ¼ 43)
Amiodarone
group (n ¼ 20)
P
value
Early mortality 0/43 0/20
JET 16/43 2/20 .026
Abbreviations and Acronyms
ICU ¼ intensive care unit
JET ¼ junctional ectopic tachycardia
TOF ¼ tetralogy of Fallot
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data, surgical procedure details (transannular or nontransannular patch),
preoperative and postoperative echocardiographic findings, and postopera-
tive inotropic support details.
Surgical Technique
The standard approach to repair was transatrial and transpulmonary.12
When the right ventricular outflow tract obstruction was not relieved by
pulmonary valvotomy and right ventricular outflow tract muscle resection,
the pulmonary annulus was opened and transannular patch was used, using
autologous pericardium or polytetrafluoroethylene as patch material. The
0.1-mm thickness polytetrafluoroethylene sheet monocusp was placed to
the transannular patch before suturing the right ventricular outflow tract.
Hegar dilators 2- to 3-mm larger than the mean normal-sized pulmonary
annulus were passed through the right ventricular outflow tract to calibrate.
Cardiopulmonary bypass techniques included bicaval cannulation, high
flow bypass (100–150 mL/kg/min), moderate hypothermia (28C), and
multidose cold-blood cardioplegia. Deep hypothermic circulatory arrest
was not used in any patient.
Arrhythmia Analysis
Continuous rhythm monitoring was done in the intensive care unit
(ICU). Rhythm analysis was also done by using a telemetry system on
the postoperative ward. JET was defined as tachycardia originating from
the His bundle with narrow QRS complexes at a rate of more than 170
beats/min. JET was initially diagnosed by the ICU staff and confirmed
by electrophysiologist consultation.
Junctional Ectopic Tachycardia Treatment
If JET developed postoperatively in a patient, treatment was initiated
with a bolus dose of amiodarone (5 mg/kg over 60 minutes) followed by
continuous amiodarone infusion (5 mg/kg/d). If an acceptable response
was not observed, the bolus was repeated up to a maximum dose of 15
mg/kg. The core temperature was reduced to 35.0C to 36.0C with a cool-
ing blanket, and sedationwas increased. Inotropic support was decreased as
tolerated, and hypokalemia and hypomagnesemia were treated appropri-
ately. After stabilization, treatment of amiodarone was continued and
weaned over 3 to 5 days. Whenever full feeding is established, amiodarone
is administered enterally.
Statistical Analysis
Categoric variables were compared with the chi-square or Fisher exact
test. Continuous variables are expressed as mean and standard deviation.
Mean values were compared with the Wilcoxon rank-sum test. Univariate
and stepwise multivariate analyses with stepwise backward selection pro-
cedure were used to evaluate variable association with the occurrence of
JET. All data were analyzed using STATA software, version 11 (StataCorp,
College Station, Tex).More than moderate PI 20/42 (48%) 8/17 (47%) .97
PG through RVOT (mm Hg) 19.2  8.5 26.1  19.8 .26
ICU stay (d) 7.0  5.0 7.2  4.9 .81
Mean hospital stay (d) 10.8  7.3 12.8  9.5 .58
PI, Pulmonary insufficiency; PG, pressure gradient; RVOT, right ventricular outflow
tract.RESULTS
Preoperative and Operative Variables
There were no differences between groups in age, weight,
and preoperative echocardiography findings (Table 1).The Journal of Thoracic and CaAortic crossclamp times were longer in the amiodarone
group (Table 2). JET was more frequently observed in the
control group (Table 2). Other postoperative echocardiogra-
phy and hospital course did not show any differences.
Postoperative Variables
There were no deaths in either cohort. There was no dif-
ference between the 2 groups in the degree of inotropic sup-
port required postoperatively (Table 3). Postoperative heart
block developed in 1 patient in the control group (1.6%).
Variables Affecting the Incidence of Junctional
Ectopic Tachycardia
The stepwise backward multiple logistic regression anal-
ysis revealed lack of prophylactic amiodarone and epineph-
rine use to be significant prognostic factors for the incidence
of JET (Table 4).
Evaluation With Outcome of Junctional Ectopic
Tachycardia
The impact of the development of JET is demonstrated in
Table 5. Patients with JETwere ventilated longer than JET-
free peers, but they did not have longer stays in the ICU or
hospital.
Amiodarone Safety
In the prophylactic amiodarone group, no hypotension or
bradycardia due to drug use was identified, and no patientrdiovascular Surgery c Volume 143, Number 1 153
TABLE 3. Postoperative inotropic support
Variables
Control
group (n ¼ 43)
Amiodarone
group (n ¼ 20)
P
value
Epinephrine 10/43 (23%) 5/20 (25%) .88
Norepinephrine 6/43 (14%) 2/20 (10%) .66
Dopamine 28/43 (65%) 13/20 (65%) 1
Milrinone 31/43 (72%) 12/20 (60%) .34
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no proarrhythmic effect of amiodarone was detected. Lung
disease or thyroid dysfunction due to amiodarone use did
not develop in any patient.DISCUSSION
Amiodarone was prophylactically applied in patients un-
dergoing primary TOF repair with a significant associated
reduction in the incidence of JET.
JET is identified as the most common tachyarrhythmia
after surgery for congenital heart disease and is well recog-
nized as a cause of low cardiac output syndrome and conse-
quent prolonged ICU stay and hospitalization.4 In the
present study, evenwith aggressive amiodarone-based treat-
ment of JET, patients in whom the arrhythmia developed
had significantly longer ventilator support times. The dura-
tion of ICU and hospital stay was also longer for patients
with JET, but this difference did not achieve statistical sig-
nificance probably because of relatively small sample sizes.
We believe it is important not to draw the conclusion that
JET is a benign arrhythmia that can simply be treated
when it occurs and hope that the absence of a statistically
significant difference in length of ICU or hospital stay be-
tween patients with and without JET in this study would
not be thus interpreted.
JET continues to be an important management consider-
ation in children undergoing surgery for congenital heart
disease and has been the subject of several contemporary re-
ports investigating risk factors and treatments of the ar-
rhythmia.1-8 A recent study from Finland showed the
incidence of JET after surgery for congenital heart disease
is 5.0%,4 with an incidence of approximately 1.0% for
all other non-JET arrhythmias (sinus tachycardia,TABLE 4. Prognostic factors for the incidence of junctional ectopic tachy
Variables
Univariate analysis
Odds ratio 95% CI
Prophylactic amiodarone 0.19 0.04–0.9
Age>6 mo 1 0.18–5.7
Early and late series 0.365 0.12–1.15
Transannular patch 1.7 0.33–9.1
Epinephrine 4.32 1.3–14.9
Dopamine 1.6 0.48–5.2
Milrinone 1.9 0.54–6.9
CI, Confidence interval.
154 The Journal of Thoracic and Cardiovascular Surgsupraventricular tachycardia, and atrial flutter). Andreasen
and colleagues5 described risk factors for JET, including
younger age at operation, longer bypass time, and higher
inotropic score. Dodge-Khatami and colleagues6 proposed
a causal relationship between surgical trauma to the bundle
of His and postoperative JET. In contrast, Rekawek and col-
leagues13 reported that longer ischemic time is the best pre-
dictor of JETand suggested that JET is not related to surgery
near the His bundle.
Many investigators have sought to discover the mecha-
nism of postoperative JET and reported the possible cause
of JETas underlying cardiac defects, type of surgery, hemo-
dynamic instability, and electrolyte imbalances13 because
of the high incidence of postoperative JET reported in
some series, even when the surgical procedure did not in-
clude the manipulation around the His bundle or right ven-
tricular muscle resection.2
It is worth pointing out that virtually all surgeons strive
for the gentlest surgical technique, shortest crossclamp
time, shortest bypass time, and lowest inotropic use, consis-
tent with the goals of the particular operation, so that virtu-
ally all of the putative risk factors identified for JET are not
practically modifiable. With that in mind, and a high inci-
dence of JET, despite an institutional approach of quick
and gentle surgery, we initiated prophylactic amiodarone.
In this series, uniform surgical technique and bypass tech-
niques including cardioplegic solution were used. Because
a single diagnosis of TOF with a uniform surgical technique
was used for study cohorts, evaluation of mechanism of JET
cannot be made in terms of manipulation of the area of the
His bundle. There was no difference between the patient
with or without JETafter surgery in age, weight, and preop-
erative pressure gradient through the right ventricular out-
flow tract. These parameters are not risk factors for JET.
Repair of TOF has been identified as the surgical proce-
dure with perhaps the highest incidence of JET after repair,
with most reports describing an incidence of JETof approx-
imately 12% to 22%.2,4,6,7,14 In the present study, the
control group had an even higher incidence of JET (37%).
We are not certain of the explanation for this increased
incidence, but we performed a secondary analysis in
which we included patients with TOF who had undergonecardia
Multivariate analysis
P value Odds ratio 95% CI P value
.039 0.15 0.027–0.81 .027
1
.08
.52
.019 5.5 1.4–22 .014
.45
.31
ery c January 2012
TABLE 5. Summary by outcome
Variables
No JET
(n ¼ 45)
JET
(n ¼ 18)
P
value
Age (mo) 3.9  3.8 5.3  9.4 .76
Weight (kg) 5.7  2.0 5.8  2.5 .95
Preoperative
PG through RVOT (mm Hg) 85  23 82  22 .34
Transannular patch 37/45 (82%) 16/18 (89%) .51
CPB time (min) 124  39 123  16 .48
AXT time (min) 80  25 84  16 .28
Dopamine 28/45 (62%) 13/18 (72%) .45
Milrinone 29/45 (64%) 14/18 (78%) .30
Epinephrine 16/45 (7%) 8/18 (44%) .015
Norepinephrine 4/45 (4%) 4/18 (22%) .15
Ventilatory time (d) 1.9  2.0 3.1  1.8 .008
ICU stay (d) 6.8  5.5 7.6  3.4 .11
Hospital stay (d) 11.0  8.2 12.5  8.0 .13
AXT, Aortic crossclamping; CPB, cardiopulmonary bypass; PG, pressure gradient;
RVOT, right ventricular outflow tract.
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Dprior palliation. In the combined group of control patients
plus previously palliated patients, the incidence of JET
was only 20%. Because the palliated patients were older
and had virtually no postrepair JET, we suggest that young
age is indeed a risk factor for JET, at least in patients who
do not receive prophylactic amiodarone. If some centers
have markedly lower JET incidence without amiodarone
prophylaxis, this prophylactic amiodarone application
may not show a beneficial reduction of JET.
Amiodarone is a class III antiarrhythmic agent that pro-
longs phase 3 of action potential of myocardium, with
both beta-blocker–like and potassium channel blocker–
like actions. Amiodarone has been reported to be effective
in managing JET after pediatric heart surgery.9-11,15 In
adult cardiac surgery, multiple studies demonstrated that
prophylactic amiodarone decreased the incidence of
postoperative atrial fibrillation,16 using a wide variety of
prophylactic regimens. Several studies showed associated
benefits of reduced ventricular arrhythmia and reduction
of hospital cost. Our study was not designed or powered
to investigate cost, and because the incidence of ventricular
arrhythmias is so low in children, we are not able to com-
ment regarding that potential benefit.
In pediatric patients, Plumpton and colleagues11 reported
adverse effects of amiodarone for postoperative JET in 3 pa-
tients with hypotension and slow junctional rhythm. Perry
and colleagues10 showed transient hypotension during the
bolus phase. In our study, hypotension or bradycardia due
to prophylactic amiodarone use did not develop in any pa-
tients in the amiodarone group. This was probably because
of the use of low doses of amiodarone and the fact that the
drug was initiated during cardiopulmonary bypass, starting
during bypass and rewarming time.
Although we are encouraged by the results of the present
study, its retrospective nature is a major limitation in theThe Journal of Thoracic and Castrength of our conclusions. Furthermore, the sample sizes
are small, and the patient population in the study was lim-
ited to a single cardiac diagnosis.
On retrospective analysis, prophylactic amiodarone
given to infants undergoing primary repair of TOF was as-
sociated with a substantial reduction in the rate of postoper-
ative JET. It is hoped that this observation will lead to
further prospective evaluation of the concept of arrhythmia
prophylaxis with studies of dosage, timing, duration, and
extension into other populations.
Limitations to the study are inherent to the retrospective
nature of data retrieval. Future randomized and blinded
study will strengthen the effect of prophylactic amiodarone
on postoperative JETafter TOF repair. Because of the small
size of each cohort, we are unable to show any difference in
the postoperative courses.CONCLUSIONS
Prophylactic amiodarone started during rewarming is
well tolerated and significantly decreases the incidence of
postoperative JET after TOF repair. Application of this pre-
emptive treatment does not cause any apparent adverse
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